Robert A. Maranchuk

Effective response of doxorubicin-sensitive and -resistant breast cancer cells to combinational siRNA therapy

Hamidreza Montazeri Aliabadi, Robert A. Maranchuk, Cezary Kucharski et al. · Journal of Controlled Release · 2013 · 57 citations

Breast Oncology, Medicine, Effective Response +9

Control of VP16 Translation by the Herpes Simplex Virus Type 1 Immediate-Early Protein ICP27

Kimberly Ellison, Robert A. Maranchuk, Kelly Mottet et al. · Journal of Virology · 2005 · 54 citations · Full text

Viral Replication, Immediate-early Protein Icp27, Viral Pathogenesis +17

Genetic Screening for Synthetic Lethal Partners of Polynucleotide Kinase/Phosphatase: Potential for Targeting SHP-1–Depleted Cancers

Todd R. Mereniuk, Robert A. Maranchuk, Anja Schindler et al. · Cancer Research · 2012 · 39 citations

Polynucleotide Kinase/phosphatase, Apoptosis, Cell Death +19

Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells

Manoj B. Parmar, Daniel Nisakar Meenakshi Sundaram, Remant Bahadur K.C. et al. · Acta Biomaterialia · 2017 · 36 citations

Tissue Engineering, Amphiphilic Polyplexes, Engineering +8

Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines

Manoj B. Parmar, Hamidreza Montazeri Aliabadi, Parvin Mahdipoor et al. · Frontiers in Bioengineering and Biotechnology · 2015 · 24 citations · Full text

Molecular Biology, Lipid-substituted Polyethylenimines, Cell Cycle +18